Losartan Potassium 25 MG Oral Tablet

INDICATIONS AND USAGE Hypertension Losartan potassium tablets USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents, including diuretics. Hypertensive Patients with Left Ventricular Hypertrophy Losartan potassium tablets USP are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients. (See PRECAUTIONS, Race and CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects, Reduction in the Risk of Stroke, Race ). Nephropathy in Type 2 Diabetic Patients Losartan potassium tablets USP are indicated for the Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. In this population, losartan potassium tablets USP reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects ).

Legacy Pharmaceutical Packaging, LLC

FDA Reported Adverse Reactions
[1] off label use    [2] drug ineffective    [3] toxicity to various agents    [4] completed suicide    [5] drug abuse    [6] diarrhoea    [7] condition aggravated    [8] nausea    [9] fatigue    [10] colitis ulcerative